Overview Financials News + Filings IR Vault Key Docs Charts Ownership Insiders |
MiddleBrook Pharmaceuticals, Inc. (MBRKQ)
|
Add to portfolio |
|
|
Price: |
$0.07
| | Metrics |
OS: |
86.5
|
M
| |
|
|
Market cap: |
$6.06
|
M
| |
|
|
Net cash:
|
$10.9
|
M
| |
$0.13
|
per share
|
EV:
|
|
| | | |
| | | | | |
TTM Valuation | | | |
EBITDA
|
($62.1)
|
M
| |
|
|
EBIT
|
($67.6)
|
M
| |
|
|
EPS |
($0.78)
| |
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
In millions, except per share items | Dec-31-09 | Dec-31-08 | Dec-31-07 | Dec-31-06 | Dec-31-05 | Dec-31-04 | Dec-31-03 | Dec-31-02 |
Revenues | 14.8 | 8.8 | 10.5 | 4.8 | 16.8 | 11.4 | 3.6 | 10.9 |
Revenue growth | 67.7% | -15.4% | 117.4% | -71.4% | 48.3% | 213.3% | -66.6% | 105.0% |
Cost of goods sold | 2.3 | 1.6 | 2.6 | 0.9 | 0.6 | 0.2 | 16.6 | 21.7 |
Gross profit | 12.6 | 7.2 | 7.9 | 3.9 | 16.3 | 11.2 | -13.0 | -10.9 |
Gross margin | 84.8% | 81.5% | 75.4% | 81.3% | 96.7% | 98.5% | -357.8% | -100.0% |
Selling, general and administrative | 69.9 | 24.4 | 26.0 | 21.3 | 10.5 | 12.2 | 6.4 | 3.3 |
EBIT | -62.6 | -36.2 | -40.1 | -43.4 | -34.0 | -34.7 | -19.4 | -14.2 |
EBIT margin | -421.4% | -409.6% | -383.7% | -901.2% | -201.6% | -305.3% | -535.1% | -130.6% |
Pre-tax income | -62.2 | -42.2 | -42.4 | -42.0 | -33.0 | -34.0 | -21.0 | -14.1 |
Income taxes | 0.2 | -0.2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Tax rate | | 0.4% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Net income | -62.3 | -42.1 | -42.4 | -42.0 | -33.0 | -34.0 | -42.1 | -14.2 |
Net margin | -419.9% | -475.4% | -405.6% | -872.9% | -195.8% | -299.4% | -1161.2% | -130.8% |
|
Diluted EPS | ($0.72) | ($0.65) | ($0.97) | ($1.38) | ($1.20) | ($1.50) | ($7.58) | ($16.37) |
Shares outstanding (diluted) | 86.5 | 65.2 | 43.8 | 30.5 | 27.4 | 22.7 | 5.6 | 0.9 |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|